Shortness of breath effects patients over the long-term after lung cancer treatment

Share this content:
Long-term lung cancer survivors suffer from dyspnea, according to a study published in the Journal of Thoracic Oncology (2010 Aug;5(8):1221-6).

For the study, Marc Feinstein, MD, and fellow researchers at Memorial Sloan-Kettering Cancer Center and UMDNJ-Robert Wood Johnson Medical School surveyed 342 survivors of early-stage lung cancer, who had their tumors removed within 1 to 6 years of the survey.

Researchers found that among the study participants, dyspnea occurred in 60% of those surveyed—nearly three times the number of patients who presented with dyspnea before their surgery. In addition, factors associated with long-term dyspnea in cancer survivors included presence of dyspnea before lung cancer surgery, reduced diffusion capacity, and lack of physical activity. The team also reported that depression symptoms, which were not very prevalent in the study sample, were strongly associated with dyspnea.

“The identification of potentially modifiable risk factors associated with dyspnea is perhaps the most significant finding,” noted Dr. Feinstein, assistant attending physician in the Pulmonary Service at Memorial Sloan-Kettering Cancer Center. “This implies that strategies which improve physical activity or relieve depressive symptoms may result in improved breathlessness.”

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs